Latest research
Latest corporate research
Latest tax enhanced reviews
Subscribe now
What we do
Corporate research services
Tax enhanced research services
Bespoke consulting services
About Hardman & Co.
Case Studies
News & events
Contact us
Twitter icon
Created with Sketch.
Latest corporate research
Detailed company analysis created specifically for investors
Latest tax enhanced research
Product reports for investors and advisors
Subscribe now
Receive our latest research as soon as it is published
Corporate Research & Analysis
Detailed company analysis created for specifically for investors
Tax Enhanced Services
Product reports for investors and advisors
Bespoke Services
Services for clients with specific needs
About Hardman & Co.
We are the longest-established commissioned research provider. Read our story
Case Studies
We help a wide range of clients with different needs. Read what they say about us
Latest Corporate research
Our research can still be accessed for free under MIFID II.
Find out more >
All Corporate research
- Update
- Monthly Report
- Sector Report
- Initiation
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Life Sciences
Media
Mining
Oil & Gas
Property
Services
Technology
Utilities
list companies
Chamberlin Plc
Industrial
Trading very difficult; forecasts lowered
By
Paul Singer
06 Feb 2019
Avacta Group plc
Life Sciences
A second wake-up call for the market
By
Dr Gregoire Pave
06 Feb 2019
Stay up-to-date with the latest research
Sign up to our newsletter
The Monthly: February 2019
05 Feb 2019
Volta Finance
Financials
February 2019 monthly
By
Mark Thomas
04 Feb 2019
Shield Therapeutics Plc
Life Sciences
Cast-iron investment
By
Dr Martin Hall
28 Jan 2019
AJ Bell
Financials
Platform for growth
By
Jason Streets
24 Jan 2019
City of London Investment Group
Financials
Solid FUM update offset by margin changes
By
Dr Brian Moretta
21 Jan 2019
Advanced Oncotherapy
Life Sciences
Important regulatory milestone: ISO approval
By
Dr Gregoire Pave
21 Jan 2019
Allergy Therapeutics plc
Life Sciences
Trading update: gaining market share
By
Dr Dorothea Hill
17 Jan 2019
1pm Plc
Financials
Interim results 1H FY’19: geared up for growth
By
Mark Thomas
16 Jan 2019
Diurnal Group Plc
Life Sciences
Chronocort – seeking regulatory advice
By
Dr Gregoire Pave
15 Jan 2019
1
2
3
...
22
Next